These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17189015)

  • 1. Haemoglobin concentrations in chronic kidney disease.
    Steinbrook R
    Lancet; 2006 Dec; 368(9554):2191-3. PubMed ID: 17189015
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemoglobin concentrations in chronic kidney disease.
    Fernandes M; Sawa H; Bellini G
    Lancet; 2007 Feb; 369(9559):365. PubMed ID: 17276763
    [No Abstract]   [Full Text] [Related]  

  • 3. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis.
    Phrommintikul A; Haas SJ; Elsik M; Krum H
    Lancet; 2007 Feb; 369(9559):381-8. PubMed ID: 17276778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemoglobin targets: we were wrong, time to move on.
    Strippoli GF; Tognoni G; Navaneethan SD; Nicolucci A; Craig JC
    Lancet; 2007 Feb; 369(9559):346-50. PubMed ID: 17276756
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythropoietin.
    Haberl M
    Aust Nurses J; 1990 Sep; 20(2):29. PubMed ID: 2268202
    [No Abstract]   [Full Text] [Related]  

  • 6. Anemia management in patients with chronic renal insufficiency.
    Kausz AT; Obrador GT; Pereira BJ
    Am J Kidney Dis; 2000 Dec; 36(6 Suppl 3):S39-51. PubMed ID: 11118157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
    Sobota JT
    Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
    [No Abstract]   [Full Text] [Related]  

  • 8. Managing anemia in dialysis patients: hemoglobin cycling and overshoot.
    Singh AK; Milford E; Fishbane S; Keithi-Reddy SR
    Kidney Int; 2008 Sep; 74(5):679-83. PubMed ID: 18337717
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of renal anemia with recombinant human erythropoietin].
    Schaefer RM; Kürner B; Zech M; Krahn R; Heidland A
    Dtsch Med Wochenschr; 1988 Jan; 113(4):125-9. PubMed ID: 3276487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of anemia in chronically dialyzed patients].
    Moynot A
    Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055
    [No Abstract]   [Full Text] [Related]  

  • 11. Erythropoietin treatment for anemia in end-stage renal disease with diabetes mellitus.
    Nakatsuka K; Hino M; Miki T; Nishizawa Y; Tabata T; Inoue T; Morii H
    Diabetes Care; 1990 Nov; 13(11):1130-1. PubMed ID: 2261828
    [No Abstract]   [Full Text] [Related]  

  • 12. Target hemoglobin level for EPO therapy in CKD.
    Parfrey PS
    Am J Kidney Dis; 2006 Jan; 47(1):171-3. PubMed ID: 16377399
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anemia and renal failure: efficacy of its control].
    Fort J
    Nefrologia; 2006; 26 Suppl 3():28-32. PubMed ID: 17469424
    [No Abstract]   [Full Text] [Related]  

  • 14. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
    von Appen K; Klinkmann H
    Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
    [No Abstract]   [Full Text] [Related]  

  • 15. Rebates for anti-anemia drugs draw response from FDA, CMS.
    Sipkoff M
    Manag Care; 2007 Jun; 16(6):17-8. PubMed ID: 17682732
    [No Abstract]   [Full Text] [Related]  

  • 16. [New treatments of anemia in chronic renal failure].
    Fernández Lorente L; Romero R
    Med Clin (Barc); 2014 Jul; 143(1):39-42. PubMed ID: 24467877
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to recombinant human erythropoietin (r-Hu EPO) and L-carnitine combination in patients with anemia of end-stage renal disease.
    Boran M; Dalva I; Gönenç F; Cetin S
    Nephron; 1996; 73(2):314-5. PubMed ID: 8773364
    [No Abstract]   [Full Text] [Related]  

  • 18. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
    Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
    Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.
    Binkley LS
    Transplant Proc; 1991 Apr; 23(2):1831-2. PubMed ID: 2053169
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current issues in erythropoietin therapy of renal anemia].
    Zakar G
    Lege Artis Med; 2007 Oct; 17(10):667-73. PubMed ID: 19227596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.